Read the latest press releases for 4D pharma plc.

Click on a news title to read full details. For Regulatory News Service (RNS) announcements please click here.

Press release archive
Clinical
4D to Present Phase Ib Clinical Data on Thetanix®
16 May 2019, 09:26
4D pharma plc (AIM: DDDD), a pharmaceutical company focusing on the development of Live…
Publications
4D announces participation in Neuro4D Conference, Frankfurt, Germany
13 May 2019, 08:00
4D’s Research and Development team is giving a poster presentation on preclinical data from the…
Publications
4D to present preclinical data on neurodegenerative disorders programme
2 May 2019, 17:16
4D pharma will present preclinical data on its neurodegenerative disorders programme targeting…
Clinical Update – MRx0518 oncology programmes
29 Apr 2019, 09:00
4D pharma plc (AIM: DDDD), a pharmaceutical company leading the development of Live Biotherapeutics,…
Participation in Microbiome Conference
8 Mar 2019, 09:00
4D announces participation in Chardan’s Inaugural Microbiome Medicines Summit, USA
4D pharma publishes mechanistic data on MRx0518
29 Jan 2019, 09:00
4D pharma announces publication of data highlighting immuno-stimulatory properties of MRx0518
4D pharma Appoints Two Non-Executive Directors
8 Jan 2019, 09:00
4D pharma plc announces the appointment of Ed Baracchini, PhD, and Professor Axel Glasmacher, MD, as…
4D pharma and MD Anderson Cancer Center to Evaluate Live Biotherapeutics in Solid Tumours
7 Jan 2019, 09:00
4D pharma plc (AIM: DDDD) and The University of Texas MD Anderson Cancer Center today announced a…
Clinical Update - Blautix Phase II study
8 Nov 2018, 12:00
4D pharma plc announces first patient enrolment in Blautix IBS Phase II study
4D Announces Positive Data From Phase Ib Study of Thetanix in Paediatric Crohn's Disease Patients
24 Sep 2018, 12:00
4D pharma plc (AIM: DDDD), announces positive top-line results for its Phase Ib study of Thetanix in…
4D asthma publication
14 Aug 2018, 08:26
Data suggests that MRx0004 is a promising next-generation therapeutic for management of asthma
Publication - microbiota as HDAC inhibitors
30 Jul 2018, 08:32
30 July 2018 -- 4D pharma plc (AIM: DDDD), a pharmaceutical company leading the development of live…
4D Presents at IHMC 2018
27 Jun 2018, 08:35
4D pharma plc (AIM: DDDD), a pharmaceutical company leading the development of live biotherapeutics,…
MHRA and HPRA clear Blautix Phase II study
13 Jun 2018, 08:37
4D pharma plc (AIM: DDDD), a pharmaceutical company leading the development of live biotherapeutics,…
Clinical Collaboration Agreement
7 Jun 2018, 08:38
4D pharma plc (AIM: DDDD), a clinical stage biopharmaceutical company, pioneering the development of…

BACK TO TOP